stars 1 stars 2 stars 3

Atomo Diagnostics is a medical device manufacturer headquartered in Sydney, Australia with offices in South Africa and the United Kingdom. Atomo Diagnostics was established to capitalise on a core belief that healthcare products offering significantly improved levels of convenience, simplicity and user experience are disproportionately disruptive and have the potential to be very successful commercial market entrants. In 2013, Atomo introduced AtomoRapid, a range of safe, simple professional use tests that deliver fast and accurate results in both clinical and community settings. In 2014, AtomoRapid HIV won Best in Show at the Medical Device Excellence Awards (MDEA) and Atomo was named Australian Emerging Company of the Year for 2014 by Johnson & Johnson Innovation. Atomo is committed to increasing the early detection and ongoing treatment of infectious and chronic diseases by making testing safer, more accurate and more accessible. Visit our website, www.atomodiagnostics.com, for more information on our company and products.

Website http://www.atomodiagnostics.com
Revenue $5.1 million
Employees 30 (24 on RocketReach)
Founded 2010
Address Level 1, 3-5 George Street, Leichhardt, New South Wales 2040, AU
Phone +61 2 9099 4750
Technologies
Industry Manufacturing, Medical Equipment Manufacturing, Manufacturing General, Health Care, Medical Devices, Medical Technology Development, Medical Device, IVD, Rapid Diagnostic Testing, Blood Based Lateral Flow Testing, Point of Care Rapid Diagnostic Testing, Over the Counter Rapid Diagnostic Testing
Web Rank 11 Million
Keywords Point Of Care Testing, Medical Technology, Rapid Diagnostics, Health Technology, Diagnostic Tests, Clinical Diagnostics, Medical Devices Manufacturing, In Vitro Diagnostics, Infectious Disease, Ivd, Disease Detection, Healthcare, Molecular Diagnostics, Poct, Quality Healthcare, Immunodiagnostics, Serological Tests
Competitors Siemens, Roche, Thermo Fisher Scientific, Abbott, BD, Hologic, Inc., Cepheid, GenMark Diagnostics, Mesa Biotech, Inc., Bio-Rad Magyarország Kft. +35 more (view full list)
SIC SIC Code 384 Companies, SIC Code 38 Companies
NAICS NAICS Code 33 Companies, NAICS Code 339 Companies

Atomo Diagnostics Questions

The Atomo Diagnostics annual revenue was $5.1 million in 2026.

John Kelly is the Founder and Chief Executive Officer of Atomo Diagnostics.

24 people are employed at Atomo Diagnostics.

Atomo Diagnostics is based in Leichhardt, New South Wales.

The NAICS codes for Atomo Diagnostics are [33, 339].

The SIC codes for Atomo Diagnostics are [384, 38].

Top Atomo Diagnostics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users